High BMI May Cut Overall Survival in HER2 & #43; Metastatic Breast Cancer

WEDNESDAY, Feb. 12, 2020 -- For patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC) treated with pertuzumab and/or trastuzumab emtansine (T-DM1), a body mass index (BMI) of ≥30 kg/m² is...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news